Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ganglioside GD2 as a marker and target on cancer stem cells

Ganglioside GD2 as a marker and target on cancer stem cells

US Patent 9846160 · Granted Dec 19, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Small molecule inhibitors of cancer stem cells and mesenchymal cancer types2025
Small molecule inhibitors of cancer stem cells and mesenchymal cancer types2023
Progenitor cells and uses thereof2015
Methods of diagnosing, preventing and treating cancer metastasis2013
Method for isolating and/or identifying mesenchymal stem cells (MSC)2012
Use of FOXC2 in diagnosing, preventing and treating cancer metastasis2012
CDDO-compounds and combination therapies thereof2010
CDDO-compounds and combination therapies thereof2008
Method of cancer treatment2007
Method of cancer treatment2005